Author

Mai A. Mansour

Institution: Badr University in Cairo

Observed institution: Badr University in Cairo

ORCID: 0000-0002-3964-0393

Observed ORCID: 0000-0002-3964-0393

OpenAlex ID: A5044266969

Identification of novel furo[2,3- d ]pyrimidine based chalcones as potent anti-breast cancer agents: synthesis, in vitro and in vivo biological evaluation

2022 · Mai A. Mansour, Mamdouh A. Oraby, et al. · RSC Advances · 21

Insecticides and testicular health: mechanisms of injury and protective natural products

2025 · Samar F. Darwish, Yasser M. Moustafa, et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 14

Elaborating piperazinyl-furopyrimidine based scaffolds as phosphoinositol-3-kinase enzyme alpha (PI3Kα) inhibitors to combat pancreatic cancer

2020 · Mai A. Mansour, Deena S. Lasheen, et al. · RSC Advances · 11

A novel furo[2,3- d ]pyrimidine-based chalcone derivative (MMK-1931) loaded chitosomes as a potential cancer therapy in an Ehrlich ascites tumour model

2025 · Walaa A. El-Dakroury, Moataz B. Zewail, et al. · Journal of drug targeting · 10

Advances in the discovery of activin receptor-like kinase 5 (ALK5) inhibitors

2024 · Mai A. Mansour, Ghaneya S. Hassan, et al. · Bioorganic Chemistry · 10

Discovery of Furopyrimidine‐Pyrazole Hybrid Compounds Targeting p53‐MDM2 Interaction as Anticancer Agents

2025 · Mai A. Mansour, Ghaneya S. Hassan, et al. · Archiv der Pharmazie · 2

The antitumor promise of furo[2,3- d ]pyrimidine: a 2016–2025 review

2026 · Mai A. Mansour, Haya A. Elshafei, et al. · RSC Advances · 1

Navigating the p53‐MDM2 Landscape: Molecular Insights and Therapeutic Strategies

2026 · Mai A. Mansour, Ghaneya S. Hassan, et al. · Archiv der Pharmazie

Works count: 8

Citation count: 69

H-index: 5

I10-index: 5